140 related articles for article (PubMed ID: 9514798)
1. Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy.
Molpus KL; Wu H; Fuller AF
Gynecol Oncol; 1998 Feb; 68(2):206-9. PubMed ID: 9514798
[TBL] [Abstract][Full Text] [Related]
2. Primary peritoneal serous psammocarcinoma with recurrent disease and metastasis: a case report and review of the literature.
Akbulut M; Kelten C; Bir F; Soysal ME; Duzcan SE
Gynecol Oncol; 2007 Apr; 105(1):248-51. PubMed ID: 17222893
[TBL] [Abstract][Full Text] [Related]
3. Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
Markman M; Webster K; Zanotti K; Rohl J; Belinson J
Gynecol Oncol; 2004 May; 93(2):390-3. PubMed ID: 15099951
[TBL] [Abstract][Full Text] [Related]
4. Successful pregnancy after fertility-sparing surgery for peritoneal psammocarcinoma: a case report.
Shah JP; Bryant CS; Kumar S; Ali-Fehmi R; Morris RT
J Reprod Med; 2009 Mar; 54(3):179-83. PubMed ID: 19370904
[TBL] [Abstract][Full Text] [Related]
5. The antiestrogen tamoxifen in the treatment of recurrent benign cystic mesothelioma.
Letterie GS; Yon JL
Gynecol Oncol; 1998 Jul; 70(1):131-3. PubMed ID: 9698490
[TBL] [Abstract][Full Text] [Related]
6. Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature.
Takahashi R; Ueda Y; Shioji M; Adachi S; Ohashi H; Morii E; Aozasa K; Yoshino K; Fujita M; Enomoto T; Kimura T; Tokuhira A
Gynecol Obstet Invest; 2012; 74(2):165-70. PubMed ID: 22584287
[TBL] [Abstract][Full Text] [Related]
7. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
8. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
[TBL] [Abstract][Full Text] [Related]
9. Primary peritoneal psammocarcinoma: A case presenting with an upper abdominal mass and elevated CA-125.
Whitcomb BP; Kost ER; Hines JF; Zahn CM; Hall KL
Gynecol Oncol; 1999 May; 73(2):331-4. PubMed ID: 10329057
[TBL] [Abstract][Full Text] [Related]
10. A unique case of ovarian psammocarcinoma with mediastinal, pulmonary, subcutaneous, and omental metastases.
Chase DM; Sparks DA; Gener M; Smith J
Arch Gynecol Obstet; 2009 Aug; 280(2):283-6. PubMed ID: 19096859
[TBL] [Abstract][Full Text] [Related]
11. Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature.
Alanbay I; Dede M; Ustün Y; Karaşahin E; Deveci S; Günhan O; Yenen MC
Arch Gynecol Obstet; 2009 Jun; 279(6):931-6. PubMed ID: 18982336
[TBL] [Abstract][Full Text] [Related]
12. Conservative surgery in a young patient with peritoneal psammocarcinoma.
Munkarah AR; Jacques SM; Qureshi F; Deppe G
Gynecol Oncol; 1999 May; 73(2):312-4. PubMed ID: 10329052
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
Hercbergs AA; Goyal LK; Suh JH; Lee S; Reddy CA; Cohen BH; Stevens GH; Reddy SK; Peereboom DM; Elson PJ; Gupta MK; Barnett GH
Anticancer Res; 2003; 23(1B):617-26. PubMed ID: 12680157
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
Martens JW; Nimmrich I; Koenig T; Look MP; Harbeck N; Model F; Kluth A; Bolt-de Vries J; Sieuwerts AM; Portengen H; Meijer-Van Gelder ME; Piepenbrock C; Olek A; Höfler H; Kiechle M; Klijn JG; Schmitt M; Maier S; Foekens JA
Cancer Res; 2005 May; 65(10):4101-17. PubMed ID: 15899800
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
[TBL] [Abstract][Full Text] [Related]
18. Primary peritoneal psammocarcinoma.
Arole VC; Deshpande KA; Jadhav DB; Jogi A
J Obstet Gynaecol Res; 2017 Aug; 43(8):1366-1372. PubMed ID: 28544349
[TBL] [Abstract][Full Text] [Related]
19. Aggressive ovarian psammocarcinoma: a case report.
Zakkouri FA; Berrada N; Kettani F; Mrabti H; Jalil A; Errihani H
Eur J Gynaecol Oncol; 2011; 32(2):214-5. PubMed ID: 21614920
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen].
Wenger FA; Zieren HU; Jacobi CA; Müller JM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
